Expression of mucin core proteins in extramammary Paget's disease
Noriko Yoshii,
Shinichi Kitajima,
Suguru Yonezawa,
Sumika Matsukita,
Mitsuru Setoyama,
Tamotsu Kanzaki,
Noriko Yoshii
Department of Dermatology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan and
Search for more papers by this authorShinichi Kitajima
Department of Research and Examination, National Sanatorium Hoshizuka Keiaien, Japan and
Search for more papers by this authorSuguru Yonezawa
Second Department of Pathology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorSumika Matsukita
Second Department of Pathology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorMitsuru Setoyama
Department of Dermatology, School of Medicine, Miyazaki Medical College, Miyazaki, Japan
Search for more papers by this authorTamotsu Kanzaki
Department of Dermatology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan and
Search for more papers by this authorNoriko Yoshii,
Shinichi Kitajima,
Suguru Yonezawa,
Sumika Matsukita,
Mitsuru Setoyama,
Tamotsu Kanzaki,
Noriko Yoshii
Department of Dermatology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan and
Search for more papers by this authorShinichi Kitajima
Department of Research and Examination, National Sanatorium Hoshizuka Keiaien, Japan and
Search for more papers by this authorSuguru Yonezawa
Second Department of Pathology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorSumika Matsukita
Second Department of Pathology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
Search for more papers by this authorMitsuru Setoyama
Department of Dermatology, School of Medicine, Miyazaki Medical College, Miyazaki, Japan
Search for more papers by this authorTamotsu Kanzaki
Department of Dermatology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan and
Search for more papers by this author Noriko Yoshii, MD, Department of Dermatology, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, 890-8520, Japan. Email: [email protected]
Abstract
Extramammary Paget's disease (EPD) is a relatively common skin cancer wherein tumor cells have mucin in their cytoplasm. However, little is known about mucin expression in EPD. We examined immunohistochemically the expression of mucin core proteins (MUC1, MUC2, MUC5AC and MUC6) in 36 cases of EPD and found different patterns of expression in intraepithelial (n = 36), microinvasive (n = 13) and invasive lesions (n = 6). In normal skin, MUC1 was expressed in the sebaceous, eccrine and apocrine glands. MUC2, MUC5AC and MUC6 were not expressed in any of these. In the 36 intraepithelial lesions, MUC1 and MUC5AC were expressed in 35 and 36 lesions, respectively. MUC1 expression was also observed in all 13 microinvasive lesions and in all six invasive lesions. In contrast to the intraepithelial lesions, a decrease or loss of MUC5AC expression was observed in five out of 13 microinvasive lesions and in all six invasive lesions. MUC2 and MUC6 were not expressed in any of the EPD lesions examined. The combination of immunohistochemical staining for MUC1 and MUC5AC was useful for identifying invasive Paget cells. The decrease or loss of MUC5AC expression may have an important role in the invasive growth of Paget cells.
References
- 1 Connolly SM. Mammary and extramammary Paget's disease. In: Freedberg IM, ed. Fitzpatrick's Dermatology in General Medicine. New York: McGraw-Hill, 1993; 919–924.
- 2
Watanabe S,
Ohnishi T,
Takahashi H et al.
A comparative study of cytokeratin expression in Paget cells located at various sites.
Cancer
1993; 72: 3323–3330.
10.1002/1097-0142(19931201)72:11<3323::AID-CNCR2820721131>3.0.CO;2-Y PubMed Web of Science® Google Scholar
- 3 Yonezawa S, Horinouchi M, Osako M et al. Gene expression of gastric type mucin (MUC5AC) in pancreatic tumors: its relationship with the biological behavior of the tumor. Pathol. Int. 1999; 49: 45–54.
- 4
Reis CA,
David L,
Nielsen PA et al.
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody.
Int. J. Cancer
1997; 74: 112–121.
10.1002/(SICI)1097-0215(19970220)74:1<112::AID-IJC19>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- 5 Gendler SJ, Lancaster CA, Taylor-Papadimitriou J et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J. Biol. Chem. 1990; 265: 15 286–15 293.
- 6 Lan MS, Batra SK, Qi WN et al. Cloning and sequencing of a human pancreatic tumor mucin cDNA. J. Biol. Chem. 1990; 265: 15 294–15 299.
- 7 Ligtenberg MJ, Vos HL, Gennissen AM et al. Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. Biol. Chem. 1990; 265: 5573–5578.
- 8 Gum JR, Byrd JC, Hicks JW et al. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J. Biol. Chem. 1989; 264: 6480–6487.
- 9 Meezaman D, Charles P, Daskal E et al. Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J. Biol. Chem. 1994; 269: 12 932–12 939.
- 10 Guyonnet-Duperat V, Audie JP, Debailleul V et al. Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? Biochem. J. 1995; 305: 211–219.
- 11 Dufosse J, Porchet N, Audie JP et al. Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem. J. 1993; 293: 329–337.
- 12 Toribara NW, Roberton AM, Ho SB et al. Human gastric mucin. Identification of a unique species by expression cloning. J. Biol. Chem. 1993; 268: 5879–5885.
- 13 Bobek LA, Tsai H, Biesbrock AR et al. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem. 1993; 268: 20 563–20 569.
- 14 Shankar V, Pichan P, Eddy RL Jr et al. Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am. J. Respir. Cell. Mol. Biol. 1997; 16: 232–241.
- 15 Lapensee L, Paquette Y, Bleau G. Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil. Steril. 1997; 68: 702–708.
- 16 Reis CA, David L, Correa P et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999; 59: 1003–1007.
- 17
Takao S,
Uchikura K,
Yonezawa S et al.
Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis.
Cancer
1999; 86: 1966–1975.
10.1002/(SICI)1097-0142(19991115)86:10<1966::AID-CNCR13>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 18 Yamashita K, Yonezawa S, Tanaka S et al. Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int. J. Cancer 1993; 55: 82–91.
- 19
Osako M,
Yonezawa S,
Siddiki B et al.
Immunohistochemical study of mucin carbohydrates and core protein in human pancreatic tumors.
Cancer
1993; 71: 2191–2199.
10.1002/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- 20 Nakamori S, Ota DM, Cleary KR et al. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994; 106: 353–361.
- 21 Higashi M, Yonezawa S, Ho JJL et al. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 1999; 30: 1347–1355.
- 22 Yonezawa S, Sueyoshi K, Nomoto M et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients. Hum. Pathol. 1997; 28: 344–352.
- 23 Zotter S, Hageman PC, Lossnitzer A, Mooi WJ, Hilgers J. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 1988; 11–12: 55–101.
- 24 Kim YS. Mucin glycoproteins in gastrointestinal malignancies and metastasis. Eur. J. Gastroenterol. Hepatol. 1993; 5: 219–225.
- 25 Girling A, Bartkova J, Burchell J, Gendler S, Gillett C, Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer 1989; 43: 1072–1076.
- 26 Kitamura H, Yonezawa S, Tanaka S, Kim YS, Sato E. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: Their relationship to prognosis. Jpn. J. Cancer Res. 1996; 87: 631–640.
- 27 Utsunomiya T, Yonezawa S, Sakamoto H et al. Expression of MUC1 and MUC2 mucins in gastric carcinomas: Its relationship with the prognosis of the patients. Clin. Cancer Res. 1998; 4: 2605–2614.
- 28 Ho SB, Roberton AM, Shekels LL, Lyftogt CT, Niehans GA, Yribara NW. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology 1995; 109: 735–747.
- 29 Bolos C, Garrido M, Real FX. MUC6 apomucin shows a distinct normal tissue distribution that correlates with lewis antigen expression in the human stomach. Gastroenterology 1995; 109: 723–734.
- 30 Kim YS. Diversity of mucin genes, structure, function, and expression. Gastroenterology 1995; 109: 999–1013.
- 31 Gum JR. Mucin genes and the proteins they encode: Structure, diversity, regulation. Am. J. Respir. Cell. Mol. Biol. 1992; 7: 557–564.
- 32 Toribara NW, Gum JR, Culhane PJ et al. MUC-2 human small intestinal mucin gene structure: Repeated arrays and polymorphism. J. Clin. Invest. 1991; 88: 1005–1013.
- 33 Gum JR, Hicks JW, Toribara NW, Siddiki B, Kim YS. Molecular cloning of human intestinal mucin (MUC) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willbrand factor. J. Biol. Chem. 1994; 269: 2440–2446.
- 34 Goldblum JR, Hart WR. Vulvar Paget's disease: A clinicopathologic and immunohistochemical study of 19 cases. Am. J. Surg. Pathol. 1997; 21: 1178–1187.
- 35 Li A, Yonezawa S, Matsukita S et al. Comparative study for histology, proliferative activity, glycoproteins, and p53 protein between old and recent colorectal adenomas in Japan. Cancer Lett. 2001; 170: 45–52.
- 36 Tsuji T. Mammary and extramammary Paget's disease: expression of Ca 15–3, Ka-93, CA 19–9 and CD44 in Paget cells and adjacent normal skin. Br. J. Dermatol. 1995; 132: 7–13.
- 37 Yasui S, Ando I, Kukita A et al. DF3 (CA15-3) antibody as a marker of cutaneous adnexal tumors. Acta Derm. Venereol. 1994; 74: 98–100.
- 38 Elder D. Tumor and cysts of the epidermis. In: Elder D, ed. Lever's Histopathology of the Skin. New York: Lippincott-Raven, 1997; 734–739.
- 39 Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J. Clin. Pathol. 2000; 53: 742–749.
- 40 Battles OE, Page DL, Johnson JE. Cytokeratins, CEA, and mucin histochemistry in the diagnosis and characterization of extramammary Paget's disease. Am. J. Clin. Pathol. 1997; 108: 6–12.
- 41 Nishi N, Tashiro M, Yoshida H. Stimulation of growth by both androgen and estrogen of the EMP-K1 transplantable tumor with androgen and estrogen receptors from human extramammary Paget's disease in nude mice. J. Natl Cancer Inst. 1992; 84: 519–523.
- 42 Kondo Y, Kashima K, Suda T et al. Expression of gastric type mucins in mammary Paget's disease. Nihon Byouri Gakkaishi 2001; 90: 251 (in Japanese).
- 43 Yonezawa S, Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol. Int. 1997; 47: 813–830.
- 44 Makiguchi Y, Hinoda Y, Imai K. Effect of MUC1 mucin and anti-adhesion molecule on tumor cell growth. Jpn. J. Cancer Res. 1996; 87: 505–511.
- 45 Ligtenberg MJL, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high level of episialin. Cancer Res. 1992; 52: 2318–2324.
- 46 Van De Wiel-van Kemenade E, Ligtenberg MJL, De Boer AJ et al. Episialin (MUC1) inhibits cytotoxic lymphocyte–target cell interaction. J. Immunol. 1993; 151: 767–776.
- 47 Wesseling J, Van Der Valk SW, Vos HL, Sonnenberg A, Hikens J. Episialin (MUC1) over-expression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol. 1995; 129: 255–265.
- 48 Agrawal B, Krants MJ, Reddish M, Longenecked BM. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat. Med. 1998; 4: 43–49.
- 49 Wesseling J, Van Der Valk SW, Hikens J. A mechanism for inhibition of E-cadherin mediated cell–cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell 1996; 7: 565–577.
Citing Literature
